Global /China /Healthcare /Drug Manufacturers - General /002550

Changzhou Qianhong Biopharma CO.,LTD

002550

• SHE: 002550 • Delayed

7.00CNY -1.3%

1.03 USD

As of 24 June 2026, Changzhou Qianhong Biopharma CO.,LTD has a market cap of $1.31B USD, ranking #9223 globally and #2480 in China. It ranks #787 in the Healthcare sector, and #299 in the Drug Manufacturers - General industry.

Global Rank

9223

Country Rank

2480

Sector Rank

787

Industry Rank

299

Key Stats

Market Cap

$1.31BUSD

8.86B CNY

Enterprise Value

$1.12BUSD

7.58B CNY

Revenue (TTM)

$218.23MUSD

1.48B CNY

EBITDA (TTM)

$55.61MUSD

376.44M CNY

Net Income (TTM)

$47.66MUSD

322.88M CNY

EBITDA Margin

25%

Profit Margin

22%

PE Ratio

27.4

PS Ratio

6.0

PB Ratio

3.1

EV/EBITDA

20.0

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Ke Wang open_in_new

Employees

979

Founded

1971

Website

qhsh.com.cn open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.3%	-7.4%	-5.6%	-12%	-20%	-9.8%	18%	22%	68%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	002550 常州千红生化制药股份有限公司 Class A ISIN: CNE100001070 Shares Out.: Shares Outstanding: 1.225B¹ Shares Float: 906.052M² TV: TradingView: SZSE: 002550 SA: Stock Analysis: SHE: 002550 YF: Yahoo Finance: 002550.SZ GF: Google Finance: SHE: 002550 BA: Barron's: 002550 MS: Morningstar: XSHE: 002550	7.00 CNY	TV: TradingView: SZSE: 002550 SA: Stock Analysis: SHE: 002550 YF: Yahoo Finance: 002550.SZ GF: Google Finance: SHE: 002550 BA: Barron's: 002550 MS: Morningstar: XSHE: 002550

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Changzhou Qianhong Biopharma CO.,LTD

Changzhou Qianhong Biopharma CO.,LTD manufactures and distributes polysaccharide and protease drugs in China. The company offers heparin sodium, heparin calcium, enoxaparin sodium, dalteparin sodium, nadroparin calcium, pancreatin, heparinoid API, kallidinogenase, and asparaginase. It also provides low molecular weight heparin, compound digestive enzyme preparations, and health products. In addition, the company exports its products. The company was founded in 1971 and is headquartered in Changzhou, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.86B 364.89B CNY 4K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.65B 336.36B CNY 4K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.51B 223.48B HKD 2K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.79B 147.32B HKD 1K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.52B 111.89B CNY 1K%	-	China
Akeso, Inc. SHEK: 9926	$16.0B 125.46B HKD 1K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 58K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 42K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 27K%	97.4	United States
Roche Holding AG SIX: RO	$316.71B 256.25B CHF 24K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$285.49B 215.59B GBP 22K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 21K%	15.1	United States

chevron_leftBack